NASDAQ:KNSA - Kiniksa Pharmaceuticals News Headlines

$8.87
-0.99 (-10.04 %)
(As of 08/25/2019 04:00 PM ET)
Today's Range
$8.81
Now: $8.87
$10.02
50-Day Range
$9.23
MA: $12.31
$15.32
52-Week Range
$8.81
Now: $8.87
$32.88
Volume100,672 shs
Average Volume69,039 shs
Market Capitalization$486.52 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.56

Headlines

Kiniksa Pharmaceuticals (NASDAQ KNSA) News Headlines

Source:
DateHeadline
Kiniksa to Present Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019Kiniksa to Present Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
finance.yahoo.com - August 19 at 11:32 AM
Q3 2019 EPS Estimates for Kiniksa Pharmaceuticals Ltd Boosted by Analyst (NASDAQ:KNSA)Q3 2019 EPS Estimates for Kiniksa Pharmaceuticals Ltd Boosted by Analyst (NASDAQ:KNSA)
www.americanbankingnews.com - August 15 at 7:17 AM
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Rating Reaffirmed by WedbushKiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Rating Reaffirmed by Wedbush
www.americanbankingnews.com - August 14 at 9:41 AM
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Given New $35.00 Price Target at JMP SecuritiesKiniksa Pharmaceuticals (NASDAQ:KNSA) Given New $35.00 Price Target at JMP Securities
www.americanbankingnews.com - August 14 at 9:35 AM
Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) to Post Q1 2020 Earnings of ($0.82) Per Share, Wedbush ForecastsKiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) to Post Q1 2020 Earnings of ($0.82) Per Share, Wedbush Forecasts
www.americanbankingnews.com - August 14 at 8:15 AM
Zacks: Analysts Expect Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) to Post -$0.76 Earnings Per ShareZacks: Analysts Expect Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) to Post -$0.76 Earnings Per Share
www.americanbankingnews.com - August 13 at 3:10 PM
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Posts Quarterly  Earnings Results, Beats Estimates By $0.03 EPSKiniksa Pharmaceuticals (NASDAQ:KNSA) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - August 13 at 11:19 AM
Kiniksas KPL-716 shows encouraging action in early-stage dermatitis studyKiniksa's KPL-716 shows encouraging action in early-stage dermatitis study
seekingalpha.com - August 12 at 8:53 PM
Kiniksa Announces Interim Data from KPL-716 Repeated-Single-Dose Phase 1b Clinical TrialKiniksa Announces Interim Data from KPL-716 Repeated-Single-Dose Phase 1b Clinical Trial
finance.yahoo.com - August 12 at 8:53 PM
Kiniksa Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline ActivityKiniksa Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity
finance.yahoo.com - August 12 at 8:53 PM
Kiniksa Pharmaceuticals to Present at the 2019 Wedbush PacGrow Healthcare ConferenceKiniksa Pharmaceuticals to Present at the 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 12:15 PM
Is Kiniksa Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?Is Kiniksa Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?
finance.yahoo.com - June 30 at 10:40 AM
Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology 
finance.yahoo.com - June 13 at 6:32 AM
The Kiniksa Pharmaceuticals (NASDAQ:KNSA) Share Price Is Down 23% So Some Shareholders Are Getting WorriedThe Kiniksa Pharmaceuticals (NASDAQ:KNSA) Share Price Is Down 23% So Some Shareholders Are Getting Worried
finance.yahoo.com - June 10 at 12:15 PM
Kiniksa to Present Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at EULAR 2019Kiniksa to Present Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at EULAR 2019
finance.yahoo.com - May 31 at 11:39 AM
Kiniksa Pharmaceuticals to Present at Upcoming Investor ConferencesKiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - May 30 at 11:44 AM
Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes ResearchKiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research
finance.yahoo.com - May 16 at 9:14 AM
Is Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?Is Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?
finance.yahoo.com - April 29 at 3:53 PM
Kiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative DermatologyKiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
finance.yahoo.com - April 18 at 12:27 PM
Kiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as DrugsKiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs
finance.yahoo.com - April 8 at 4:19 PM
Kiniksa Pharmaceuticals LtdKiniksa Pharmaceuticals Ltd
www.bloomberg.com - March 19 at 10:49 AM
Kiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiology’s 68th Annual Scientific SessionKiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiology’s 68th Annual Scientific Session
finance.yahoo.com - March 18 at 11:16 AM
Kiniksa Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Recent Corporate and Pipeline ActivityKiniksa Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Recent Corporate and Pipeline Activity
finance.yahoo.com - March 7 at 12:40 PM
Kiniksa announces active U.S. IND application for MavrilimumabKiniksa announces active U.S. IND application for Mavrilimumab
seekingalpha.com - January 3 at 11:16 AM
Kiniksa Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare ConferenceKiniksa Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 17 at 10:58 AM
Kiniksa Pharmaceuticals Ltd. (KNSA) Highlights Phase 2 Clinical Data and Commences Pivotal Phase 3 Clinical TrialKiniksa Pharmaceuticals Ltd. (KNSA) Highlights Phase 2 Clinical Data and Commences Pivotal Phase 3 Clinical Trial
www.streetinsider.com - December 12 at 3:29 PM
Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical TrialKiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial
finance.yahoo.com - December 11 at 11:16 AM
Kiniksa Pharmaceuticals Ltd.Kiniksa Pharmaceuticals Ltd.
www.barrons.com - December 10 at 3:29 PM
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Update on FDA Review of Investigational NDA for Mavrilimumab in Giant Cell ArteritisKiniksa Pharmaceuticals, Ltd. (KNSA) Reports Update on FDA Review of Investigational NDA for Mavrilimumab in Giant Cell Arteritis
www.streetinsider.com - December 7 at 10:26 AM
Kiniksa Pharma down 15% on FDA hold on mavrilimumabKiniksa Pharma down 15% on FDA hold on mavrilimumab
seekingalpha.com - December 6 at 3:31 PM
Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell ArteritisKiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis
finance.yahoo.com - December 6 at 10:37 AM
Kiniksa Reports Third Quarter 2018 Financial Results and Pipeline ProgressKiniksa Reports Third Quarter 2018 Financial Results and Pipeline Progress
finance.yahoo.com - November 1 at 9:12 AM
Kiniksa Pharmas KPL-716 shows encouraging action in early-stage dermatitis studyKiniksa Pharma's KPL-716 shows encouraging action in early-stage dermatitis study
seekingalpha.com - September 17 at 3:23 PM
Kiniksa Presents KPL-716 Clinical Data at the 27th European Academy of Dermatology and VenereologyKiniksa Presents KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
finance.yahoo.com - September 15 at 3:21 PM
Week Ahead In Pharmaceuticals: 5 Stocks To Watch (KNSA, INCY, ANAB...)Week Ahead In Pharmaceuticals: 5 Stocks To Watch (KNSA, INCY, ANAB...)
www.finanznachrichten.de - September 9 at 7:58 AM
Kiniksa Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare ConferenceKiniksa Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference
finance.yahoo.com - August 29 at 7:48 AM
Kiniksa to Present Late-Breaking KPL-716 Clinical Data at the 27th European Academy of Dermatology and VenereologyKiniksa to Present Late-Breaking KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
finance.yahoo.com - August 29 at 7:48 AM
Kiniksa Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare ConferenceKiniksa Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 3 at 6:54 AM
Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional SharesKiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 25 at 3:16 PM
Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences ConferenceKiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference
finance.yahoo.com - June 15 at 5:31 AM
Breaking Down Kiniksa Pharmaceuticals Ltd’s (NASDAQ:KNSA) Ownership StructureBreaking Down Kiniksa Pharmaceuticals Ltd’s (NASDAQ:KNSA) Ownership Structure
finance.yahoo.com - June 12 at 3:15 PM
Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public OfferingKiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
finance.yahoo.com - June 6 at 3:15 PM
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel